|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.355 MYR | +10.94% |
|
+14.52% | -7.79% |
| 19/04 | China's drugmakers can't sell mRNA shots but haven't quit yet | RE |
| 27/03 | Pharmaniaga Berhad Appoints Tuan Drs. Imam Fathorrahman as Independent and Non Executive Member of Audit Committee | CI |
Pharmaniaga Berhad reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was MYR 880.45 million compared to MYR 962.17 million a year ago. Net income was MYR 2.65 million compared to MYR 27.73 million a year ago.
Basic earnings per share from continuing operations was MYR 0.002 compared to MYR 0.0212 a year ago. Diluted earnings per share from continuing operations was MYR 0.002 compared to MYR 0.0212 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -7.79% | 98.27M | |
| +20.87% | 72.45B | |
| -4.64% | 23.46B | |
| +4.89% | 8.59B | |
| +7.11% | 8.35B | |
| -23.73% | 7.88B | |
| +13.92% | 5.21B | |
| -0.59% | 4.11B | |
| +7.85% | 4.09B | |
| +20.65% | 3.6B |
PHARMANIAGA 
